Investigation of the effects of the blood plasma levels of C16 ceramides on the course of non-alcoholic fatty liver disease
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 5
Abstract
Objective — to investigate the dependence of the blood plasma levels of C16 ceramides on the degree of liver steatosis in patients with nonalcoholic fatty liver disease (NAFLD) based on the results of steatomometry in comparison with healthy subjects. Materials and methods. The study involved 20 patients with NAFLD and 20 healthy people. Among them, 10 (50 %) were men and 10 (50 %) women. The mean age of patients was 50.2 ± 1.93 years. The mean body weight in the main group was 103.5 ± 1.9 kg, and the mean BMI was 33.1 ± 0.5. The men blood glucose level was 5.6 ± 0.1 mmol/L; HOMA index 2.4 ± 0.2. The results of steatometry showed the mean damping factor of 2.70 ± 0.2, which corresponded to S2 degree of liver steatosis. NAFLD diagnosis was verified based on patient’s complaints, anamnesis of the disease, objective examination including anthropometric parameters, laboratory methods (blood glucose, glycosylated hemoglobin, HOMA index), parameters of steatometry, elastometry and mass spectrometry liquid chromatography (Shimadzu Nexera X2 UHPLC, Shimadzu LCMS-8045 mass spectrometer). The control group consisted of 20 healthy age- and gender-matching subjects with normal body mass. Results. NAFLD patients demonstrated the significantly increased blood plasma levels of C16 ceramides up to 0.402 ± 0.01 μmol/L, compared to healthy subjects levels of 0.271 ± 0.01 μmol/L (p < 0.001), that corresponded to a moderate steatosis degree. The glucose levels and NOMA index in NAFLD patients were within the normal limits of 5.6 ± 0.1 mmol/L and 2.4 ± 0.2, respectively. Conclusions. The elevated blood plasma levels of C16 ceramides significantly (p < 0.001) affected the degree of steatosis compared to the healthy people, they proved to be more sensitive marker of insulin resistance.
Authors and Affiliations
L. L. Pavlovskyi, V. V. Chernyavskyi, V. P. Shipulin, L. M. Kupchyk
Keywords
Related Articles
- EP ID EP675095
- DOI 10.30978/MG-2019-5-14
- Views 116
- Downloads 0
Vegetative accompaniment of the combined course of gastroesophageal reflux disease in young patients with autoimmune thyroiditis
Objective — to establish the presence of autonomic dysfunction and to assess the frequency and severity of its manifestations in patients with autoimmune thyroiditis (AIT) and gastroesophageal reflux disease (GERD) with...
Masks of autoimmune hepatitis. Clinical observations
Autoimmune hepatitis is a diagnosis of exclusion. Based on literature data, a third of patients are diagnosed with other autoimmune diseases, which are combined with AIH, which aggravates the severity of the disease and...
The results of multicenter study of efficacy of Helicobacter pylori eradication therapy, conducted according to the recommendations of Maastricht V Consensus Report
Objective — to study efficacy and safety of two weeks quadruple therapy with high doses of pantoprazole, bismuth subcitrate, clarithromycin, amoxicillin with concomitant adjuvant symbiotic therapy (Saccharomyces boulardi...
Clinical Practice Guidelines of European Association for the Study of the Liver (EASL) on nutrition in chronic liver disease. Part 2
-
The role of thyroid hormones in the formation mechanisms of motor-secretory disorders in patients with gastroesophageal reflux disease with concomitant autoimmune thyroiditis
Objective — to study the role of thyroid hormones in the formation of motor-secretory disorders with the comorbid course of gastroesophageal reflux disease (GERD) and autoimmune thyroiditis (AIT). Materials and methods....